This document discusses maintaining joint function through various treatment options. It begins by noting the increased use of complementary and alternative medicine (CAM) in the United States. It then discusses the high prevalence of arthritis. The document recommends COX-2 inhibitors as first-line drugs for pain treatment. It also reviews studies showing cardiovascular risks associated with COX-2 inhibitors like Vioxx. Several nutritional supplements are described that may help reduce inflammation and pain, including glucosamine, chondroitin, MSM, chicken collagen, flaxseed, and boswellia. Testimonials provide positive anecdotes about a joint health product called Arthroclem. The document promotes Arthroclem and provides background on the